4//SEC Filing
MEDGENICS, INC. 4
Accession 0001144204-14-009870
CIK 0001138776operating
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:31 PM ET
Size
10.1 KB
Accession
0001144204-14-009870
Insider Transaction Report
Form 4
MEDGENICS, INC.MDGN
Pearlman Andrew
President and CEO
Transactions
- Exercise/Conversion
Common Stock
2014-02-12$3.14/sh+11,168$35,068→ 51,730 total - Sale
Common Stock
2014-02-12$9.00/sh−11,168$100,512→ 40,562 total - Exercise/Conversion
Option Award (right to buy)
2014-02-12−11,168→ 34,632 totalExercise: $3.14Exp: 2014-09-13→ Common Stock (11,168 underlying)
Holdings
- 94(indirect: By Spouse)
Common Stock
- 1,719(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2013.
- [F2]The option award became fully exercisable on September 13, 2013 in accordance with the terms of the reporting person's separation agreement entered into upon his resignation as the issuer's President and Chief Executive Officer.
Documents
Issuer
MEDGENICS, INC.
CIK 0001138776
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001138776
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:31 PM ET
- Size
- 10.1 KB